Dr. Ziva Cooper is the Director of the UCLA Center for Cannabis and Cannabinoids. She is also an Associate Professor in the Department of Psychiatry and Biobehavioral Sciences and Department of Anesthesiology at the David Geffen School of Medicine. Her current research involves understanding variables that influence both the therapeutic potential and adverse effects of cannabis and cannabinoids through double-blind, …
Cannabimimetics and The Pharmacist’s Role in Cannabis Medicine with Swathi Varanasi, PharmD
Dr. Swathi Varanasi is a bilingual pharmacist specializing in integrative and preventative health. Dr. Swathi has paved the way for other healthcare professionals to pursue non-traditional career paths through creating postdoctoral training programs, industry internships, and online courses focused on integrative medicine and patient-centered shared decision-making. She co-founded and serves as Chief Scientific Officer of the international award-winning clean beauty …
Cannabinoids’ Affect on Human Microbiomes with Pam Miles and Cindy Orser, PhD
Pam Miles is the CEO and founder of Apothercare, a company that partners with scientists performing women’s health research. Cindy Orser, PhD is currently Chief Scientific Officer at CLIP LABS, a cannabis testing laboratory in California, and she has more than 25 years of experience innovating technologies related to cannabis, human diagnostics, and even detecting biothreat agents. Cindy is also a …
Performing Clinical Trials on Cannabinoid Products with Jeff Chen, MD
Dr. Jeff Chen is the Co-founder and CEO of Radicle Science, a health tech company generating history’s first dataset and AI to prove and predict the effects of health and wellness products. Previously, he was the Founder and Exec Director of the UCLA Cannabis Research Initiative. At CannMed 2022, Dr. Chen presented results for Radicle Health’s ACES study, a randomized …
Coffee Talk Live from CannMed 2022 Part 1 with Ethan Russo, Eloise Theisen, and Bonni Goldstein
CannMed 2022 is officially in the books. Thank you to all our attendees, presenters, sponsors, exhibitors, media partners, and team members behind the scenes who make it all possible. It was great to see everyone in person again and learn about the latest advancements in the field. We discussed novel cannabinoids, new treatment protocols, exciting new advances in breeding and cultivation, …
The Therapeutic Potential of Minor Cannabinoids with Kevin Spelman, PhD
Dr. Kevin Spelman returns to discuss what research has been done on the minor cannabinoids. The major cannabinoids, Delta-9 THC and CBD, have gotten most of the attention when it comes to cannabis medicine research. But we know that cannabis medicine is a team effort, and there are a variety of compounds that contribute to the entourage effect, including terpenoids, flavonoids, …
Expanding Access to Consistent, Quality Cannabis Medicine with Jamie Brambila
Jaime Brambila and his wife Nicole specialize in coaching and educating patients about the clinical use of cannabinoids and other plant-based medicines. The principal aspects of their mission are to democratize plant-based medicine and democratize the science, taking the complex pharmacological information and breaking it down so everyone can understand the therapeutic potential. At CannMed 2022, Jaime will present a …
Using Biomarkers to Measure Cannabis Medicine Effectiveness with Itzhak Kurek, PhD
Itzhak Kurek, PhD is CEO & Co-Founder of Cannformatics. Itzhak and his team are measuring the effectiveness of cannabis-based medicines using biomarkers. So far, they have identified dozens of cannabis-responsive biomarkers that can be used to objectively quantify the physiological impact of medical cannabis treatment and provide a tool for investigating the metabolic pathways affected by medical cannabis and CBD. …
Reviewing Research on Cannabis and COVID-19 with Ethan Russo, MD
Dr. Ethan Russo returns to the podcast to help us make sense of the slew of studies and articles claiming cannabis can treat and/or prevent COVID-19 infection. Dr. Russo is a board-certified neurologist, a psychopharmacology researcher, an author, a lecturer, and a consultant. He is a CannMed 2022 Keynote Presenter, where he will present on Cannabis and Psychiatry. Although Dr. …
Cannabis as an Alternative to Common Pharmaceuticals with Bonni Goldstein, MD
Dr. Bonni Goldstein returns to the podcast to discuss examples where cannabis may be a safer and more effective therapeutic than traditional pharmaceutical drugs. Bonni is one of the country’s most respected and experienced medical cannabis physicians, having treated thousands of patients with medical cannabis. She is the owner and medical director of Canna-Centers Wellness & Education. She is Clinical …